✦ LIBER ✦

Defining Optimal Therapeutic Outcomes in Chronic Hepatitis

✍ Scribed by Mauricio Lisker-Melman; Gregory S. Sayuk

Book ID: 113467052
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 134 KB
Volume: 38
Category: Article
ISSN: 0188-4409
DOI: 10.1016/j.arcmed.2006.10.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic advances in chronic hepatiti

Therapeutic advances in chronic hepatitis B

✍ CHING LUNG LAI 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Defining Patient-Reported Outcomes in Ch

Defining Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease

✍ Singer, Jonathan P.; Yusen, Roger D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Progress in Defining Optimal Treatment O

Progress in Defining Optimal Treatment Outcome in Schizophrenia

✍ Remington, Gary; Foussias, George; Agid, Ofer 📂 Article 📅 2010 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 162 KB

Achieving Optimal Outcomes in Chronic Ly

Achieving Optimal Outcomes in Chronic Lymphocytic Leukaemia

✍ Professor Terry J. Hamblin 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 317 KB

Patients' and physicians' needs; definin

Patients' and physicians' needs; defining therapeutic gaps in severe chronic pain

✍ Marie Fallon 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 704 KB

Hepatitis B virus DNA levels and outcome

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B

✍ Chien-Jen Chen; Hwai-I Yang; Uchenna H. Iloeje; The REVEAL-HBV Study Group 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 2 views

Serum hepatitis B virus (HBV) DNA levels can fluctuate markedly during the course of chronic HBV infection. Both case-control and cohort studies have shown a significant, dose-response association between serum HBV DNA levels measured at the time of initial evaluation and the subsequent risk of cirr